[go: up one dir, main page]

AU2002210580A1 - Drug delivery system - Google Patents

Drug delivery system

Info

Publication number
AU2002210580A1
AU2002210580A1 AU2002210580A AU1058002A AU2002210580A1 AU 2002210580 A1 AU2002210580 A1 AU 2002210580A1 AU 2002210580 A AU2002210580 A AU 2002210580A AU 1058002 A AU1058002 A AU 1058002A AU 2002210580 A1 AU2002210580 A1 AU 2002210580A1
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210580A
Other languages
English (en)
Inventor
Juha Ala-Sorvari
Timo Haapakumpu
Harri Jukarainen
Jarkko Ruohonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of AU2002210580A1 publication Critical patent/AU2002210580A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU2002210580A 2000-10-20 2001-10-11 Drug delivery system Abandoned AU2002210580A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69222400A 2000-10-20 2000-10-20
US09692224 2000-10-20
PCT/FI2001/000879 WO2002032433A1 (fr) 2000-10-20 2001-10-11 Systeme d'administration de medicament

Publications (1)

Publication Number Publication Date
AU2002210580A1 true AU2002210580A1 (en) 2002-04-29

Family

ID=24779722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210580A Abandoned AU2002210580A1 (en) 2000-10-20 2001-10-11 Drug delivery system

Country Status (2)

Country Link
AU (1) AU2002210580A1 (fr)
WO (1) WO2002032433A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1629844B2 (fr) 2004-07-13 2012-04-18 Bayer Schering Pharma Oy Système de délivrance retardé avec dose initiale controlée
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
AU2018340266A1 (en) 2017-09-27 2020-03-05 Bayer Oy A method for modifying release of a therapeutically active agent from an elastomeric matrix

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107339B (fi) * 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties

Also Published As

Publication number Publication date
WO2002032433A1 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001288388A1 (en) Substance delivery system
AU2001264887A1 (en) Drug delivery device
AU2001235009A1 (en) Drug delivery apparatus
AU2001238386A1 (en) Medication delivery devices
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
HUP0401438A3 (en) Drug delivery system
IL155272A0 (en) Systems for optimized drug delivery
AU2002244142A1 (en) Integrated medication delivery system
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
AU4947100A (en) Drug delivery device
AU2001283359A1 (en) Drug release (delivery system)
AUPR573001A0 (en) Lymphatic drug delivery system
AU2001281171A1 (en) Medication dispensing system
AU2001270963A1 (en) Transdermal drug delivery system
AU2001260244A1 (en) Product delivery system
AU2002222138A1 (en) Drug delivery system
AU2001244854A1 (en) Local drug delivery
AU2002210580A1 (en) Drug delivery system
AUPR146700A0 (en) Drug delivery system
AU2002218904A1 (en) Pharmaceutical delivery system
AU2001238040A1 (en) Offer delivery system
HK1065475A (en) Drug delivery system
AU4808000A (en) Drug delivery system
AU2002228323A1 (en) Spaced drug delivery system